WHO ICTRP trial
Potassium-competitive acid blocker-based third-line triple therapy in…
JPRN-UMIN000025252 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000025252 |
|---|---|
| Public title | Potassium-competitive acid blocker-based third-line triple therapy in Helicobacter Pylori eradication |
| Scientific title | Potassium-competitive acid blocker-based third-line triple therapy in Helicobacter Pylori eradication - Potassium-competitive acid blocker-based third-line triple therapy in Helicobacter Pylori eradication |
| Primary sponsor | Kochi medical school |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | chronic gastritis with H.Pylori infection |
| Interventions | P-cab 20mg bid + MNZ 250mg bid + STFX 100mg bid x 7days |
| Registration date | Dec 13, 2016 |
| Target size | 50 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: